MedTrace Logo

Relation of Non-invasively Measured Parameters to Clinical Outcomes in CHF Patients

NCT04548024 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-12-10

No results posted yet for this study

Summary

Our aim is to assess whether changes in CO, CI and SVR as measured using the Biobeat wearable, wireless, non-invasive device during IV diuretic administration in an outpatient setting among CHF patients correlate with short-term clinical change measured using symptoms questionnaires, change in weight and urine output. We will also assess the correlation between baseline values of those parameters and long-term clinical outcomes, measured by HF hospitalizations and the change in disease perception and quality of life reported in questionnaires.

Conditions

  • Congestive Heart Failure

Interventions

DEVICE

Short term monitoring

By using the Biobeat monitoring device, we will monitor CHF patients during an outpatient visit and during treatment with diuretics.

Sponsors & Collaborators

  • Biobeat Technologies Ltd.

    lead INDUSTRY

Principal Investigators

  • Dean Nachman, MD · The Hadassah Ein Kerem Medical Center, Jerusalem, Israel

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-10
Primary Completion
2021-11-10
Completion
2021-12-10
FDA Device
Yes

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04548024 on ClinicalTrials.gov